Pay in 4 interest-free payments of $5.87 Learn more
Ships within 48 hours · Estimated delivery Sep 27 - Oct 2
Phase 2b completed in T2D) Status: Investigational not approved by FDA or EMA Heres what makes it different from everything else on the market and in the pipeline: - Semaglutide (Ozempic/Wegovy/Rybelsus): GLP-1 only - Tirzepatide (Mounjaro/Zepbound): GLP-1 + GIP - Retatrutide (investigational): GLP-1 + GIP + Glucagon - Amycretin : GLP-1 + Amylin Different receptor pairing
Averill-Bates DA (2023)
Metabolism Support: The lipotropic compounds in our injections help enhance your body's ability to metabolize fat
The retatrutide + MOTS-c stack swaps amylin satiety for mitochondrial AMPK support
US$ 20.02
US$ 28.19
US$ 27.56
US$ 29.95
US$ 24.75
